CH:R2US ETF Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

R2US Analyst Ratings

Moderate Buy

1218 Buy

496 Hold

48 Sell

Based on the consensus analyst ratings on 1,762 stocks held in CH:R2US.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

R2US 12 Month Forecast

Average Price Target

CHF63.93

Based on the average price target on 1,762 stocks. Derived from Wall Street analysts offering 12-month price targets on CH:R2US holdings in the last 3 months. The average price target is CHF63.93 with a high forecast of CHF76.50 and a low forecast of CHF52.71. The average price target represents a 44.71% change from the last price of CHF44.18.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"50":"CHF50","77":"CHF77","56.75":"CHF56.8","63.5":"CHF63.5","70.25":"CHF70.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":76.504,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF76.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":63.932,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF63.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.711,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF52.71</span>\n  </div></div>","useHTML":true}}],"tickPositions":[50,56.75,63.5,70.25,77],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.24,53.18338461538462,55.126769230769234,57.07015384615385,59.01353846153847,60.95692307692308,62.90030769230769,64.84369230769231,66.78707692307692,68.73046153846154,70.67384615384616,72.61723076923077,74.56061538461539,{"y":76.504,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.24,52.216307692307694,53.19261538461539,54.16892307692308,55.14523076923077,56.121538461538464,57.097846153846156,58.07415384615385,59.05046153846154,60.02676923076923,61.003076923076925,61.97938461538462,62.95569230769231,{"y":63.932,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.24,51.353153846153845,51.466307692307694,51.57946153846154,51.69261538461539,51.80576923076923,51.91892307692308,52.03207692307692,52.14523076923077,52.258384615384614,52.371538461538464,52.484692307692306,52.597846153846156,{"y":52.711,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":55.07,"date":1711929600000,"info":"<div>Price: <b>CHF55<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.23,"date":1714521600000,"info":"<div>Price: <b>CHF52<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53.16,"date":1717372800000,"info":"<div>Price: <b>CHF53<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.84,"date":1719792000000,"info":"<div>Price: <b>CHF53<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":56.7,"date":1722470400000,"info":"<div>Price: <b>CHF57<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":54.03,"date":1725235200000,"info":"<div>Price: <b>CHF54<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53.07,"date":1727740800000,"info":"<div>Price: <b>CHF53<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.38,"date":1730419200000,"info":"<div>Price: <b>CHF55<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":61.89,"date":1733097600000,"info":"<div>Price: <b>CHF62<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":58.92,"date":1735862400000,"info":"<div>Price: <b>CHF59<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":59.6,"date":1738540800000,"info":"<div>Price: <b>CHF60<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.9,"date":1740960000000,"info":"<div>Price: <b>CHF56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":51.24,"date":1743465600000,"info":"<div>Price: <b>CHF51<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF76.50

Average Price TargetCHF63.93

Lowest Price TargetCHF52.71

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

R2US Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TNYA

Tenaya Therapeutics, Inc.

9 Buy

0 Hold

0 Sell

Strong Buy

$10.14

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GBIO

Generation Bio Co.

3 Buy

2 Hold

0 Sell

Moderate Buy

$7.33

xxxxxxxxxxxxxxxxxxxxxxxxxxx

JSPR

Jasper Therapeutics, Inc.

11 Buy

0 Hold

0 Sell

Strong Buy

$60.38

xxxxxxxxxxxxxxxxxxxxxxxxxxx

INZY

Inozyme Pharma, Inc.

8 Buy

0 Hold

0 Sell

Strong Buy

$13.29

xxxxxxxxxxxxxxxxxxxxxxxxxxx

VTYX

Ventyx Biosciences, Inc.

4 Buy

1 Hold

0 Sell

Strong Buy

$15.33

R2US Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF

Please check back later or explore other ETFs for potential investment opportunities.

R2US ETF FAQ

What is CH:R2US’s average 12-month price target, according to analysts?

Based on analyst ratings, CH:R2US’s 12-month average price target is CHF63.93.

What is CH:R2US’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:R2US, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CH:R2US a Buy, Sell or Hold?

CH:R2US has a consensus rating of Moderate Buy which is based on 1218 buy ratings, 496 hold ratings and 48 sell ratings.

What is CH:R2US’s price target?

The average price target for CH:R2US is CHF63.93. This is based on 1762 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is CHF76.50 ,the lowest forecast is CHF52.71. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about CH:R2US?

CH:R2US’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1762 Wall Streets Analysts.

How can I buy shares of CH:R2US?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing